Dkk-1 shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(1) ERK1/2 inhibition reduces vascular calcification by activating miR-126-3p-DKK1/LRP6 pathwayTheranosticsJanuary 1, 2021Zeng P, Yang J, Liu L, Yang X, Yao Z, Ma C, Zhu H, Su J, Zhao Q, Feng K, et al.

(2) Dual Pharmacological Targeting of HDACs and PDE5 Inhibits Liver Disease Progression in a Mouse Model of Biliary Inflammation and FibrosisCancersDecember 13, 2020Claveria-Cabello A, Colyn L, Uriarte I, Latasa MU, Arechederra M, Herranz JM, Alvarez L, Urman JM, Martinez-Chantar ML, Banales JM, et al.

(3) Activation of the miR-371/372/373 miRNA Cluster Enhances Oncogenicity and Drug Resistance in Oral Carcinoma CellsInternational journal of molecular sciencesDecember 11, 2020Lin SC, Wu HL, Yeh LY, Yang CC, Kao SY, Chang KW.

(5) Agonists of epoxyeicosatrienoic acids reduce infarct size and ameliorate cardiac dysfunction via activation of HO-1 and Wnt1 canonical pathwayProstaglandins & other lipid mediatorsJanuary 1, 2015Cao J, Tsenovoy PL, Thompson EA, Falck JR, Touchon R, Sodhi K, Rezzani R, Shapiro JI, Abraham NG.

(7) The Wnt antagonist Dickkopf-1 increases endothelial progenitor cell angiogenic potentialArteriosclerosis, thrombosis, and vascular biologyDecember 1, 2010Smadja DM, d'Audigier C, Weiswald LB, Badoual C, Dangles-Marie V, Mauge L, Evrard S, Laurendeau I, Lallemand F, Germain S, et al.

(8) S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cellsJournal of cellular and molecular medicineJune 1, 2008Esposito G, Scuderi C, Lu J, Savani C, De Filippis D, Iuvone T, Steardo L Jr, Sheen V, Steardo L.

Dkk-1 shRNA Plasmid (h)